كوبا تقود العالم من تحت الحصار في البيوتكنولوجي والإنقاذ تتمرغ في وحل الفشل والفساد

Quote: [The increase of the Cuban biotechnological products portfolio and of exports transformed biotechnology into one of the strategic sectors of the economy. This factor – among others – motivated the creation, in December 2012, of the BioCubaFarma Business group, which integrated the work of 38 institutions of the Scientific Hub West of Havana and of the former QUIMEFA Business Group. According to its deputy director, Doctor Eduardo Martínez Díaz, BioCubaFarma is coordinating today the work of 31 enterprises and 62 productive installations. The group has a human capital of 22,000 workers; its installations currently produce 569 generic medicines out of the 857 in the basic table of the country’s medicines. The enterprise is working with more than 450 products corresponding to RandD programs, has 900 sanitary registries in more than 50 countries and has been given more than 1,800 patents abroad.